US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5612053A
(en)
*
|
1995-04-07 |
1997-03-18 |
Edward Mendell Co., Inc. |
Controlled release insufflation carrier for medicaments
|
US6540993B1
(en)
|
1995-06-27 |
2003-04-01 |
Wyeth |
Method of treating inflammatory bowel disease using a topical formulation of IL-11
|
AU2068797A
(en)
*
|
1996-01-29 |
1997-08-20 |
Edward Mendell Co. Inc. |
Sustained release excipient
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
USRE37053E1
(en)
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5846568A
(en)
*
|
1996-09-19 |
1998-12-08 |
Xyrofin Oy |
Directly compressible lactitol and method
|
US6129905A
(en)
*
|
1997-04-21 |
2000-10-10 |
Aeropharm Technology, Inc. |
Aerosol formulations containing a sugar as a dispersant
|
EP0876814A1
(de)
*
|
1997-05-07 |
1998-11-11 |
"PHARLYSE", Société Anonyme |
Trägerstoff für Trockenpulverinhalator, Verfahren zu dessen Herstellung und diesen enthaltende Arzneimittel
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
IN186245B
(de)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US6433040B1
(en)
*
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6946117B1
(en)
*
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
JP3005657B2
(ja)
*
|
1997-11-19 |
2000-01-31 |
彰 堀金 |
凍結乾燥方法、装置および凍結乾燥物
|
US7022683B1
(en)
*
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
JP2002531491A
(ja)
|
1998-12-11 |
2002-09-24 |
ノストラム・ファーマスーティカルズ・インコーポレイテッド |
ヒドロコロイドおよびセルロースエーテルを含む持続放出性錠剤
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
WO2001013891A2
(en)
*
|
1999-08-25 |
2001-03-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
EP1216037A2
(de)
*
|
1999-09-21 |
2002-06-26 |
Emory University |
Verfahren und zusammensetzungen zur behandlung von bluttplätchen-zusammenhängenden krankheiten, mit mpl hemmenden agenten
|
DE60038536T2
(de)
*
|
1999-09-30 |
2009-06-10 |
Penwest Pharmaceuticals Co. |
Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
|
AU2001230533A1
(en)
*
|
2000-02-04 |
2001-08-14 |
Kissei Pharmaceutical Co. Ltd. |
Powdered preparation for inhalation and powder inhalant containing the same packed
|
GB0008660D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Arakis Ltd |
The treatment of respiratory diseases
|
GB0009468D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU6124601A
(en)
|
2000-05-10 |
2001-11-20 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
ES2632461T3
(es)
|
2000-06-27 |
2017-09-13 |
Vectura Limited |
Formulaciones para su uso en dispositivos inhaladores
|
US20020106368A1
(en)
*
|
2000-07-28 |
2002-08-08 |
Adrian Bot |
Novel methods and compositions to upregulate, redirect or limit immune responses to peptides, proteins and other bioactive compounds and vectors expressing the same
|
IL155102A0
(en)
*
|
2000-10-03 |
2003-10-31 |
Penwest Pharmaceuticals Co |
Delivery system for multi-pharmaceutical active materials at various release rates
|
EP1920763B2
(de)
|
2000-11-30 |
2022-06-15 |
Vectura Limited |
Pharmazeutische Zusammensetzungen zur Inhalation
|
EP2168571B1
(de)
*
|
2000-11-30 |
2018-08-22 |
Vectura Limited |
Inhalierbare Arzneizusammensetzung
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
EP1345629A2
(de)
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Inhalationspartikel mit verzögerter freigabe
|
US6777000B2
(en)
*
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7494669B2
(en)
*
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US20030190360A1
(en)
*
|
2001-03-13 |
2003-10-09 |
Baichwal Anand R. |
Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment
|
GB0107106D0
(en)
*
|
2001-03-21 |
2001-05-09 |
Boehringer Ingelheim Pharma |
Powder inhaler formulations
|
US20030051728A1
(en)
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
US6759029B2
(en)
*
|
2001-05-24 |
2004-07-06 |
Alexza Molecular Delivery Corporation |
Delivery of rizatriptan and zolmitriptan through an inhalation route
|
WO2002094240A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of physiologically active compounds through an inhalation route
|
US7498019B2
(en)
|
2001-05-24 |
2009-03-03 |
Alexza Pharmaceuticals, Inc. |
Delivery of compounds for the treatment of headache through an inhalation route
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7090830B2
(en)
*
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
US6805853B2
(en)
*
|
2001-11-09 |
2004-10-19 |
Alexza Molecular Delivery Corporation |
Delivery of diazepam through an inhalation route
|
EP1392258B1
(de)
*
|
2001-05-24 |
2008-11-26 |
Alexza Pharmaceuticals, Inc. |
Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation
|
AU2002303868B2
(en)
*
|
2001-05-24 |
2008-09-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of antihistamines through an inhalation route
|
DE60228231D1
(de)
*
|
2001-05-24 |
2008-09-25 |
Alexza Pharmaceuticals Inc |
Verabreichung von anti-parkinsonmitteln durch inhalation
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
WO2002094216A2
(en)
*
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of stimulants through an inhalation route
|
JP2005503425A
(ja)
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
所定の吸入ルートによる薬剤エステルの送出
|
US20070122353A1
(en)
*
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
US6482429B1
(en)
*
|
2001-06-20 |
2002-11-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Stable powder inhalation dosage formulation
|
US20040166155A1
(en)
*
|
2001-06-29 |
2004-08-26 |
Luca Dobetti |
Drug activation process and vibrational mill therefor
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
ATE376832T1
(de)
*
|
2001-07-06 |
2007-11-15 |
Penwest Pharmaceuticals Co |
Verzögert freisetzende formulierungen von oxymorphon
|
CN1610551A
(zh)
*
|
2001-07-06 |
2005-04-27 |
恩德制药公司 |
用作止痛剂的6-羟基羟吗啡酮的肠胃外给药
|
WO2003026743A2
(en)
*
|
2001-09-26 |
2003-04-03 |
Penwest Pharmaceuticals Company |
Opioid formulations having reduced potential for abuse
|
WO2003035095A1
(en)
*
|
2001-10-19 |
2003-05-01 |
Maxim Pharmaceuticals, Inc. |
Use of histamine to treat liver disease
|
US6896894B2
(en)
|
2001-10-30 |
2005-05-24 |
Battelle Memorial Institute |
Proteins stabilized with polysaccharide gums
|
PT1455755E
(pt)
*
|
2001-11-20 |
2013-06-18 |
Civitas Therapeutics Inc |
Composições particuladas melhoradas para distribuição pulmonar
|
US20030129250A1
(en)
*
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
AU2002363947A1
(en)
*
|
2001-11-21 |
2003-07-24 |
Alexza Molecular Delivery Corporation |
Delivery of caffeine through an inhalation route
|
JP2005514393A
(ja)
*
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
SE0200657D0
(sv)
*
|
2002-03-04 |
2002-03-04 |
Astrazeneca Ab |
Novel Formulation
|
EP1480691A4
(de)
*
|
2002-03-05 |
2007-11-28 |
Univ State Cleveland |
Agglomerierte teilchen für die abgabe eines arzneimittels in aerosolform
|
AU2003230805A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
WO2003086358A1
(en)
*
|
2002-04-12 |
2003-10-23 |
Campina Nederland Holding B.V. |
Excipient for use in dry powder inhalation preparations
|
US20030204180A1
(en)
*
|
2002-04-30 |
2003-10-30 |
Kimberly-Clark Worldwide, Inc. |
Temperature responsive delivery systems
|
WO2003094900A1
(en)
|
2002-05-13 |
2003-11-20 |
Alexza Molecular Delivery Corporation |
Delivery of drug amines through an inhalation route
|
SI1531794T1
(sl)
*
|
2002-06-28 |
2017-12-29 |
Civitas Therapeteutics, Inc. |
Epinefrin za vdihavanje
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
AU2003262804A1
(en)
*
|
2002-08-22 |
2004-03-11 |
Nutrition 21, Inc. |
Arginine silicate inositol complex and use thereof
|
US7550133B2
(en)
*
|
2002-11-26 |
2009-06-23 |
Alexza Pharmaceuticals, Inc. |
Respiratory drug condensation aerosols and methods of making and using them
|
JP2006514633A
(ja)
*
|
2002-11-26 |
2006-05-11 |
アレックザ ファーマシューティカルズ, インコーポレイテッド |
吸入によって送達される抗精神病薬を用いた頭痛の治療
|
AU2003294470B2
(en)
*
|
2002-11-26 |
2009-09-17 |
Alexza Pharmaceuticals, Inc. |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
US20040105818A1
(en)
*
|
2002-11-26 |
2004-06-03 |
Alexza Molecular Delivery Corporation |
Diuretic aerosols and methods of making and using them
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
WO2004075920A1
(ja)
*
|
2003-02-26 |
2004-09-10 |
Otsuka Pharmaceutical Co., Ltd. |
経肺投与用徐放性製剤学的組成物
|
WO2004104490A1
(en)
|
2003-05-21 |
2004-12-02 |
Alexza Pharmaceuticals, Inc. |
Self-contained heating unit and drug-supply unit employing same
|
GB0312148D0
(en)
|
2003-05-28 |
2003-07-02 |
Aventis Pharma Ltd |
Stabilized pharmaceutical products
|
US6994726B2
(en)
*
|
2004-05-25 |
2006-02-07 |
Calcitec, Inc. |
Dual function prosthetic bone implant and method for preparing the same
|
NO319624B1
(no)
|
2003-09-15 |
2005-09-05 |
Trouw Internat Bv |
Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
|
NZ545921A
(en)
*
|
2003-09-19 |
2009-09-25 |
Penwest Pharmaceuticals Co |
Delayed released dosage forms
|
US20050118267A1
(en)
*
|
2003-09-19 |
2005-06-02 |
Penwest Pharmaceuticals Co. |
Chronotherapeutic dosage forms
|
WO2005060960A2
(en)
*
|
2003-12-11 |
2005-07-07 |
Maxim Pharmaceuticals, Inc. |
Use of histamine to treat bone disease
|
EP1697035B1
(de)
*
|
2003-12-22 |
2017-11-15 |
Warren H. Finlay |
Pulverbildung durch atmosphärische sprühgefriertrocknung
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
GB0409703D0
(en)
*
|
2004-04-30 |
2004-06-02 |
Vectura Ltd |
Pharmaceutical compositions
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
US20060002913A1
(en)
*
|
2004-06-22 |
2006-01-05 |
Gehlsen Kurt R |
Use of histamine and related compounds to treat disorders affecting muscle function
|
EP1763344A1
(de)
*
|
2004-06-29 |
2007-03-21 |
Boehringer Ingelheim International GmbH |
Medikamente zur inhalation mit steroiden und einem anticholinergikum
|
US20060004076A1
(en)
*
|
2004-06-30 |
2006-01-05 |
Inflabloc Pharmaceuticals, Inc. |
Co-administration of dehydroepiandrosterone (DHEA) congener with pharmaceutically active agents for treating inflammation
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
CA2631493A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
ES2334164T3
(es)
*
|
2005-12-15 |
2010-03-05 |
Acusphere, Inc. |
Procedimiento de preparacion de formulaciones farmaceuticas a base de particulas para administracion parenteral.
|
JP4907191B2
(ja)
*
|
2006-02-17 |
2012-03-28 |
日本発條株式会社 |
導電性接触子ユニット
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
US20070286814A1
(en)
*
|
2006-06-12 |
2007-12-13 |
Medispray Laboratories Pvt. Ltd. |
Stable aerosol pharmaceutical formulations
|
WO2008030557A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US9032971B2
(en)
*
|
2006-11-15 |
2015-05-19 |
Philip Morris Usa Inc. |
Moist tobacco product and method of making
|
EA018036B1
(ru)
|
2006-11-27 |
2013-05-30 |
Х. Лундбекк А/С |
Гетероариламидные производные
|
WO2008080170A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Alexza Pharmaceuticals, Inc. |
Mixed drug aerosol compositiions
|
EP2121088B1
(de)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
JP5671001B2
(ja)
|
2009-03-26 |
2015-02-18 |
パルマトリックス,インコーポレイテッド |
肺疾患を治療するための乾燥粉末製剤および方法
|
CA2754684A1
(en)
*
|
2009-03-26 |
2010-09-30 |
Pulmatrix, Inc. |
Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
CN107412212B
(zh)
|
2009-05-29 |
2021-01-22 |
珍珠治疗公司 |
经肺递送长效毒蕈碱拮抗剂及长效β2肾上腺素能受体激动剂的组合物及相关方法与系统
|
CA2793241C
(en)
*
|
2010-03-22 |
2020-07-14 |
Bio-Synectics Inc. |
Method for preparing nano-particles
|
EP2448571B1
(de)
|
2010-08-30 |
2013-06-12 |
Pulmatrix, Inc. |
Einatembares trockenpulver mit calciumlactat, natriumchlorid und leukin
|
EP2611438B1
(de)
|
2010-08-30 |
2020-04-01 |
Pulmatrix Operating Company, Inc. |
Trockenpulverformulierungen und verfahren zur behandlung von lungenerkrankugen
|
DK3470057T3
(da)
|
2010-09-29 |
2021-11-22 |
Pulmatrix Operating Co Inc |
Kationiske tørpulvere omfattende magnesiumsalt
|
MX354828B
(es)
|
2010-09-29 |
2018-03-22 |
Pulmatrix Operating Co Inc |
Polvos secos de cationes metálicos monovalentes para inhalación.
|
CN107596518B
(zh)
|
2012-02-29 |
2021-04-23 |
普马特里克斯营业公司 |
可吸入干粉剂
|
JP6013450B2
(ja)
*
|
2012-03-14 |
2016-10-25 |
株式会社Lttバイオファーマ |
慢性閉塞性肺疾患改善剤
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
EP2844227B1
(de)
|
2012-05-03 |
2020-11-18 |
Kala Pharmaceuticals, Inc. |
Pharmazeutische nanopartikel mit verbessertem mukosalem transport
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
RU2696582C2
(ru)
|
2013-03-15 |
2019-08-05 |
Перл Терапьютикс, Инк. |
Способы и системы кондиционирования дисперсных кристаллических материалов
|
WO2014165303A1
(en)
|
2013-04-01 |
2014-10-09 |
Pulmatrix, Inc. |
Tiotropium dry powders
|
US11191735B2
(en)
|
2015-03-13 |
2021-12-07 |
Nutrition 21, Llc |
Arginine silicate for periodontal disease
|
EA038755B1
(ru)
|
2015-11-12 |
2021-10-14 |
Грейбаг Вижн, Инк. |
Агрегирующие микрочастицы для обеспечения замедленного высвобождения терапевтического агента для внутриглазной доставки
|
US20170135969A1
(en)
|
2015-11-12 |
2017-05-18 |
Jds Therapeutics, Llc |
Topical arginine-silicate-inositol for wound healing
|
AU2017318672B2
(en)
|
2016-09-01 |
2022-03-10 |
Nutrition 21, Llc |
Magnesium biotinate compositions and methods of use
|
CN111201040A
(zh)
|
2017-05-10 |
2020-05-26 |
灰色视觉公司 |
用于医学疗法的缓释微粒及其悬浮液
|
EP3870229A1
(de)
*
|
2018-10-22 |
2021-09-01 |
IOI Oleo GmbH |
Additiv für ein zur verpressung zu formkörpern vorgesehenes pulver
|
CA3118583A1
(en)
|
2018-11-02 |
2020-05-07 |
Nutrition 21, Llc |
Compositions containing inositol-stabilized arginine silicate complexes and inositol for improving cognitive function in video gamers
|
AU2020407071A1
(en)
|
2019-12-16 |
2022-07-07 |
Nutrition 21, Llc |
Methods of production of arginine-silicate complexes
|